Q-Line Biotech Limited

QLINE NSE Healthcare Medical Equipment & Supplies

Strengths

  • Moderate debt: debt-to-equity of 0.91.
  • Comfortable interest cover: operating profit covers interest about 5.2 times.
  • Return on equity is healthy at 25.9%.
  • Return on capital employed is healthy at 22.5%.
  • Net profit margin is strong at 16.4%.
  • Promoters hold a majority stake (67.51%).

!Watch-points

No notable watch-points flagged by the automated checks.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
3.58

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreModerate
4 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 1,694 Cr
Current Price
High / Low₹ 730.00 / 431.00
Stock P/E30.00
Book Value
Dividend Yield0.00%
ROCE22.50%
ROE25.90%
Face Value₹ 10.00
Debt to Equity0.91
PEG Ratio1.43
EV / EBITDA17.61
Industry PE37.70
P/B Ratio
EPS₹ 34.24
Debt₹ 225 Cr
PAT Margin16.37%
Cash PAT₹ 67 Cr
ICR5.16
Promoter Holding67.51%
FII Holding1.67%
DII Holding10.14%
Public Holding20.67%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Educational data only. Not a recommendation to buy, sell or hold any security.